DIEGO
RINCÓN RODRÍGUEZ
Profesor asociado
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (6)
2024
-
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Hepatology
-
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
Journal of Hepatology, Vol. 81, Núm. 1, pp. 76-83
2020
-
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis
Hepatology, Vol. 72, Núm. 6, pp. 1924-1934
2019
2017
-
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237
-
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort
Journal of Viral Hepatitis, Vol. 24, Núm. 4, pp. 304-311